Home/Filings/4/0001213900-25-033142
4//SEC Filing

Ryan Jane 4

Accession 0001213900-25-033142

CIK 0001191070other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 8:02 AM ET

Size

5.7 KB

Accession

0001213900-25-033142

Insider Transaction Report

Form 4
Period: 2025-04-16
Ryan Jane
Director
Transactions
  • Award

    Restricted Stock Units

    2025-04-16+6,7837,013 total
    Common Stock (6,783 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
  • [F2]Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Issuer

Neuphoria Therapeutics Inc.

CIK 0001191070

Entity typeother

Related Parties

1
  • filerCIK 0002028936

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 8:02 AM ET
Size
5.7 KB